PRIMARY OPEN ANGLE GLAUCOMA
Clinical trials for PRIMARY OPEN ANGLE GLAUCOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY OPEN ANGLE GLAUCOMA trials appear
Sign up with your email to follow new studies for PRIMARY OPEN ANGLE GLAUCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Glaucoma supplement trial halted early – no clear results
Disease control TerminatedThis study tested whether a daily dietary supplement called GlaucoCetin could improve vision in people with open-angle glaucoma who already had some vision loss. Only 12 participants were enrolled before the trial was terminated early. The supplement contained a mix of ingredient…
Matched conditions: PRIMARY OPEN ANGLE GLAUCOMA
Phase: NA • Sponsor: Wills Eye • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Glaucoma Drug-Eluting contact lens trial halted after single patient
Disease control TerminatedThis study tested a special contact lens that slowly releases the glaucoma drug latanoprost, aiming to replace daily eye drops. Only one person enrolled before the study was stopped early. The goal was to check safety and whether the lens could lower eye pressure, but no conclusi…
Matched conditions: PRIMARY OPEN ANGLE GLAUCOMA
Phase: PHASE1 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC